According to the BfArM, there is a lively exchange with representatives of various countries about German experiences with DiGA. Alongside the exchange about projects, there are also many informal conversations.
The prescription figures for German DiGA, which still have room for improvement, are also under observation. In this context, industry experts point to the importance of functioning distribution channels.
One possible option here is a partnership with a pharmaceutical company that already has strong distribution structures, in order to reach target groups effectively despite limited financial resources.
Handelsblatt reports on the international interest in DiGA in this article: https://www.handelsblatt.com/inside/digital-health/app-auf-rezept-diga-koennten-internationale-maerkte-erschliessen/29699004.html
You can also read more about collaborations between pharmaceutical companies and DiGA manufacturers here: https://www.handelsblatt.com/inside/digital-health/start-up-das-steckt-hinter-vertriebspartnerschaften-fuer-diga/29711352.html